NEW YORK (GenomeWeb News) – Life sciences marketing company Genycell will distribute and sell ImaGenes' clone collection in Spain and Portugal, ImaGenes said today.

Granada, Spain-based Genycell will market ImaGenes clone collections, which includes open reading frame clones from Invitrogen and Genecopoeia, as well as the ORFeome Collection, which is a National Institutes of Health-led initiative to provide most human ORFs as a source of sequence-validated cDNA, ImaGenes said.